Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5067244011 | Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5067245012 | Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | est un(e) (attribut) | Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | a une forme pharmaceutique (attribut) | Cutaneous powder | true | Inferred relationship | Some | ||
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has precise active ingredient | Sulfacetamide sodium | true | Inferred relationship | Some | 1 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has basis of strength substance (attribute) | Sulfacetamide sodium | true | Inferred relationship | Some | 1 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has precise active ingredient | bacitracine (substance) | true | Inferred relationship | Some | 2 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has basis of strength substance (attribute) | bacitracine (substance) | true | Inferred relationship | Some | 2 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has concentration strength numerator unit | Unit | true | Inferred relationship | Some | 2 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has precise active ingredient | Neomycin sulfate | true | Inferred relationship | Some | 3 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has basis of strength substance (attribute) | Neomycin sulfate | true | Inferred relationship | Some | 3 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)